CN110295169A - A kind of miRNA and its application for killing brown paddy plant hopper - Google Patents
A kind of miRNA and its application for killing brown paddy plant hopper Download PDFInfo
- Publication number
- CN110295169A CN110295169A CN201910564291.XA CN201910564291A CN110295169A CN 110295169 A CN110295169 A CN 110295169A CN 201910564291 A CN201910564291 A CN 201910564291A CN 110295169 A CN110295169 A CN 110295169A
- Authority
- CN
- China
- Prior art keywords
- plant hopper
- paddy plant
- brown paddy
- mir
- nlu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001498622 Cixius wagneri Species 0.000 title claims abstract description 68
- 108091070501 miRNA Proteins 0.000 title claims abstract description 44
- 239000002679 microRNA Substances 0.000 title claims abstract description 40
- 230000002147 killing effect Effects 0.000 title abstract description 10
- 238000002347 injection Methods 0.000 claims abstract description 43
- 239000007924 injection Substances 0.000 claims abstract description 43
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 31
- 108091036066 Three prime untranslated region Proteins 0.000 claims abstract description 14
- 239000000243 solution Substances 0.000 claims abstract description 11
- 239000003223 protective agent Substances 0.000 claims abstract description 4
- 241000819999 Nymphes Species 0.000 claims description 27
- 239000012154 double-distilled water Substances 0.000 claims description 21
- 238000000520 microinjection Methods 0.000 claims description 11
- 238000010790 dilution Methods 0.000 claims description 9
- 239000012895 dilution Substances 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 210000001015 abdomen Anatomy 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 230000000857 drug effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 23
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 9
- 235000009566 rice Nutrition 0.000 abstract description 9
- 230000006378 damage Effects 0.000 abstract description 7
- 239000002243 precursor Substances 0.000 abstract description 7
- 230000003828 downregulation Effects 0.000 abstract description 6
- 230000035800 maturation Effects 0.000 abstract description 5
- 230000001665 lethal effect Effects 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 230000009261 transgenic effect Effects 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 59
- 239000003153 chemical reaction reagent Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 19
- 230000004087 circulation Effects 0.000 description 19
- 239000002299 complementary DNA Substances 0.000 description 19
- 239000007788 liquid Substances 0.000 description 18
- 108091008146 restriction endonucleases Proteins 0.000 description 14
- 239000003112 inhibitor Substances 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 230000004083 survival effect Effects 0.000 description 12
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 11
- 238000011144 upstream manufacturing Methods 0.000 description 11
- 238000004925 denaturation Methods 0.000 description 10
- 230000036425 denaturation Effects 0.000 description 10
- 241000209094 Oryza Species 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 241000238631 Hexapoda Species 0.000 description 8
- 239000005089 Luciferase Substances 0.000 description 8
- 230000029087 digestion Effects 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000007862 touchdown PCR Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 102100031780 Endonuclease Human genes 0.000 description 6
- 238000011529 RT qPCR Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000001976 enzyme digestion Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 230000001376 precipitating effect Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108010042407 Endonucleases Proteins 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 108010052090 Renilla Luciferases Proteins 0.000 description 3
- 241000932813 Rice grassy stunt tenuivirus Species 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010864 dual luciferase reporter gene assay Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229960004756 ethanol Drugs 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 241001466044 Delphacidae Species 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 108700011259 MicroRNAs Proteins 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 101150111044 Ubx gene Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000009938 salting Methods 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 108700035323 Drosophila a Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 101000974349 Homo sapiens Nuclear receptor coactivator 6 Proteins 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 108700015679 Nested Genes Proteins 0.000 description 1
- 241001556089 Nilaparvata lugens Species 0.000 description 1
- 102100022929 Nuclear receptor coactivator 6 Human genes 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 241000144068 Rice ragged stunt virus Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 101150016491 chsA gene Proteins 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 101150083707 dicer1 gene Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 108091029067 miR-11 stem-loop Proteins 0.000 description 1
- 108091028838 miR-2 stem-loop Proteins 0.000 description 1
- 108091055813 miR-6 stem-loop Proteins 0.000 description 1
- 108091065445 miR-6-4 stem-loop Proteins 0.000 description 1
- 108091053743 miR-6-5 stem-loop Proteins 0.000 description 1
- 108091055911 miR-6-6 stem-loop Proteins 0.000 description 1
- 108091031684 miR-9a stem loop Proteins 0.000 description 1
- 108091068703 miR-9a-1 stem-loop Proteins 0.000 description 1
- 108091054719 miR-9a-2 stem-loop Proteins 0.000 description 1
- 108091031360 miR-9a-3 stem-loop Proteins 0.000 description 1
- 108091047352 miR-9a-6 stem-loop Proteins 0.000 description 1
- 108091057016 miR-9a-7 stem-loop Proteins 0.000 description 1
- 108091038655 miR-9a-8 stem-loop Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 230000008212 organismal development Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 101150036535 prc gene Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
- A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A kind of application the present invention provides miRNA and its for killing brown paddy plant hopper, the technical solution has probed into a possibility that inhibiting brown paddy plant hopper to grow using gene regulation method by laboratory facilities, screening obtains the miRNA, i.e. Nlu-mir-9a that a kind of pair of brown paddy plant hopper has lethal effect on this basis.The initial transcript of Nlu-mir-9a has been cloned, Nlu-mir-9a precursor and Nlu-mir-9a maturation body sequence are disclosed.Prove that Nlu-mir-9a can act on 3 ' UTR of NlUbx gene, and the expression of negative regulation NlUbx.Husking is obstructed when brown paddy plant hopper being made to grow to advanced age (or emergence) by low age, finally dead because of stiff and feeding.Based on the new property found above, Nlu-mir-9a can be acted on brown paddy plant hopper using injection system, to realize killing effect；It can also be used and prepares brown paddy plant hopper protective agents；The gene constructed transgenic rice lines can be also based on, so that it is expressed Nlu-mir-9a precursor and Nlu-mir-9a maturation body, for preventing and treating the harm of brown paddy plant hopper.
Description
Technical field
The present invention relates to technical field of molecular biology, and in particular to a kind of miRNA and its for killing answering for brown paddy plant hopper
With.
Background technique
Brown paddy plant hopper belongs to Semiptera, Delphacidae (Hemiptera:Delphacidae), be important pests on rice it
One.Brown paddy plant hopper feeding habits are single, the minority oryza plant such as rice of only causing harm；It, which is endangered, has concealment, burst and destructiveness etc.
Feature.In addition, brown paddy plant hopper can also propagate Rice grassy stunt virus (rice grassy stunt virus), tingia dwarf virus
(rice ragged stunt virus), wilting dwarf virus (rice wilted stunt virus).According to statistics, China is close
The Rice Cropping producing region of half is all caused harm by brown paddy plant hopper is different degrees of, and the loss of the paddy as caused by brown paddy plant hopper every year is up to
100~1,500,000 tons.Since 21 century, brown paddy plant hopper all presents increased year by year in the hazard area and outburst number of each rice region
Trend.The problems such as prevention and treatment of brown paddy plant hopper at present, relies primarily on chemical prevention, resulting drug resistance gets worse, it would be highly desirable to seek
Look for new control of insect measure.
MicroRNA is a kind of single-stranded microRNA for only having 18~25 nucleotide, be widely present in nematode, drosophila,
In plant and eucaryote including people, it thus is unable to coding protein without open reading frame, sequence is being evolved
Upper highly conserved, there are apparent tissue specificity and temporals for its expression in growth course.MiRNA in vivo
Can cooperate with the elements such as AGO, Dicer, TRBP, PACT formed miRISC, miRISC can by degradation mRNA or inhibit its translate two
The different mechanism of kind carrys out the expression of negative regulation target gene.
MiRNA receives more extensive concern because its function has the characteristics that conservative in the research of insect.With black
Various insects based on abdomen drosophila a large number of studies show that, miRNA takes part in the growth and development of insect, development by metamorphosis, reproduction, exempts from
The almost all of physiology course such as epidemic disease.The expression of its target gene can be inhibited and then inhibit corresponding transcription by being overexpressed miRNA,
It will lead to organismal development deformity or even death when serious.Such as mir-2 is overexpressed in Groton bug, it is overexpressed in drosophila
Mir-6 and mir-11 can cause insect dead situation occur.Research at present about brown paddy plant hopper miRNA is also relatively fewer,
Zhang etc. inhibits the intracorporal miRNAs of brown paddy plant hopper to function by building dicer1 deletion mutation, can significantly inhibit ovum mother
The formation of cell.Mir-2703 is overexpressed in brown paddy plant hopper can inhibit the expression of chitin synthetase gene CHSA, lead to nymph
Husking is difficult and dead.But it yet there are no the example or report using miRNA prevention and treatment brown paddy plant hopper.
Summary of the invention
The present invention is directed to be directed to the technological deficiency of the prior art, a kind of miRNA is provided and its for killing answering for brown paddy plant hopper
With to expand the molecular biology control method of brown paddy plant hopper.
Inhibition is played to brown paddy plant hopper, is killed another technical problem to be solved by the present invention is that can be acted on by gene regulation
The specific gene for effect of going out, is still not clear.
The invention solves another technical problem be the killing effect principle of Nlu-mir-9a gene pairs brown paddy plant hopper, still
It is indefinite.
To realize the above technical purpose, the invention adopts the following technical scheme:
The nucleotide sequence of a kind of miRNA, the miRNA are as shown in SEQ ID NO:1.
On this basis, invention further provides the applications that above-mentioned miRNA is used to kill brown paddy plant hopper.
Preferably, the application is that the miRNA is injected in brown paddy plant hopper body.
Preferably, the injection dosage of every brown paddy plant hopper is 50~100ng.
Preferably, the brown paddy plant hopper is brown paddy plant hopper nymph.
Preferably, the injection, comprising the following steps: by miRNA RNase-free ddH2O is diluted to
5ng/nL concentration；3 age in days brown paddy plant hopper nymphs are taken, the CO for being first 180~220mL/min with throughput2To the brown paddy plant hopper nymph
15s is anaesthetized, is then using microinjection instrument to inject from the position between the brown paddy plant hopper nymph outside of belly mesopodium under stereomicroscope
MiRNA solution after the dilution, miRNA injection dosage are 50~100ng.
On this basis, invention further provides the applications that above-mentioned miRNA is used to prepare brown paddy plant hopper protective agents.
Preferably, the dosage form of the drug is injection.
Preferably, the drug effect is in 3 ' UTR of NlUbx gene, and the expression water of negative regulation NlUbx gene
It is flat.
It is described brown to fly preferably, when the drug hinders brown paddy plant hopper to grow to advanced age by low age or the husking of the when of emergence
Lice dies of stiff and feeding.
A kind of application the present invention provides miRNA and its for killing brown paddy plant hopper, the technical solution pass through laboratory facilities
A possibility that inhibiting brown paddy plant hopper to grow using gene regulation method is probed into, screening obtains a kind of pair of brown paddy plant hopper tool on this basis
There are the miRNA of lethal effect, i.e. Nlu-mir-9a.The initial transcript of Nlu-mir-9a is cloned, before disclosing Nlu-mir-9a
Body and Nlu-mir-9a maturation body sequence.Prove that Nlu-mir-9a can act on 3 ' UTR of NlUbx gene, and negative regulation
The expression of NlUbx.Husking is obstructed when brown paddy plant hopper being made to grow to advanced age (or sprout wings) by low age, finally because stiff and take
Food and it is dead.Based on the new property found above, Nlu-mir-9a can be acted on brown paddy plant hopper using injection system, to realize
Killing effect；It can also be used and prepares brown paddy plant hopper protective agents；The gene constructed transgenic rice lines can be also based on, its table is made
Up to Nlu-mir-9a precursor and Nlu-mir-9a maturation body, for preventing and treating the harm of brown paddy plant hopper.
Detailed description of the invention
Fig. 1 is the analysis of Nlu-mir-9a minimum free energy and secondary structure prediction figure in the specific embodiment of the invention；Its
Middle part A is primary Nlu-mir-9a；Part B is precursor Nlu-mir-9a；It analyzes result and derives from RNAfold
WebServer。
Fig. 2 is to inject mimics and inhibitors to Nlu-mir-9a expression in the specific embodiment of the invention
Influence result figure；In figure, A, part B are injection mimics to Nlu-mir-9a table in long wing strain (A) and brachypterism strain (B)
Up to horizontal influence；C, the part D is injection inhibitors to Nlu-mir-9a table in long wing strain (C) and brachypterism strain (D)
Up to horizontal influence.
Fig. 3 is to inject influence of the mimics and inhibitors to NlUbx expression in the specific embodiment of the invention
Result figure；In figure, A, part B are to inject mimics to the shadow of NlUbx expression in long wing strain (A) and brachypterism strain (B)
It rings；C, the part D is the influence for injecting inhibitors to NlUbx expression in long wing strain (C) and brachypterism strain (D).
Fig. 4 is to inject the influence result figure of Ubx gene pairs brown paddy plant hopper survival rate in the specific embodiment of the invention；In figure,
Part A is the survival rate of long wing strain；Part B is the survival rate of brachypterism strain.
Fig. 5 is Dual-Luciferase gene report carrier structure chart in the specific embodiment of the invention.
Fig. 6 is Dual-Luciferase gene reporter assay result figure in the specific embodiment of the invention；In figure, part A is wild
The Dual-Luciferase reporter assay of raw type carrier；Part B is the Dual-Luciferase reporter assay of 1 carrier of saltant type；C portion is prominent
The Dual-Luciferase reporter assay of 2 carrier of modification.
Fig. 7 is in the specific embodiment of the invention, and brown paddy plant hopper 3 age nymph injects the survival after Nlu-mir-9a mimics
Rate experimental result picture；In figure, part A is the survival rate (50ng dosage) of long wing strain；Part B is the survival rate of brachypterism strain
(50ng dosage)；C portion is the survival rate (100ng dosage) of long wing strain；The part D is survival rate (the 100ng agent of brachypterism strain
Amount).
Specific embodiment
Below by specific embodiments of the present invention will be described in detail.In order to avoid excessive unnecessary details,
It will not be described in detail in following embodiment to belonging to well known structure or function.Approximation used in following embodiment
Language can be used for quantitative expression, show to allow quantity to have certain variation in the case where not changing basic function.It is fixed except having
Adopted outer, technical and scientific term used in following embodiment has the phase being commonly understood by with those skilled in the art of the invention
Same meaning.
1, the full-length clone of Nlu-mir-9a and sequence analysis
1.1 materials and methods
1.1.1 miRNA is extracted
It is carried out referring to miRNeasy Mini Kit (article No. 217004, QIAGEN, the Germany) reagent provided and step.It is first
First test sample is placed in the glass homogenizer of Liquid nitrogen precooler be fully ground after, be added 700 μ L QIAzol reagents cracking tissue and
Cell.On the silica gel film medium for the being integrated to adsorption column miRNA released specific under the conditions of certain salting liquid and pH,
The small molecular weight impurities such as DNA, protein, salinity are removed by washing step.30 μ L RNase-free H are added2O elutes miRNA.
1.1.2 the cDNA full-length clone of miRNA
RACE (Rapid amplification of cDNA ends) full-length clone technology with one section in transcript
Know and obtains the complete 5 ' end of the transcript and 3 ' terminal sequences based on sequence.RACE reaction is referring to SMARTer RACE 5 '/3 '
The reagent and step that Kit (article No. 634858, Clontech, Japan) is provided carry out.Respectively using 1 μ g miRNA as starting template,
Using 5 '-CDS primer A, 3 '-CDS primer A and Oligonucleotide as primer, divide under the action of reverse transcriptase
Not He Cheng 5 '-RACE cDNA and 3 '-RACE cDNA, the RACE-cDNA of acquisition include that the specificity of one section of known array connects
Head.Use ddH2O is stand-by after diluting 10 times.
Touchdown PCR: being respectively amplification template with 5 '-RACE cDNA and 3 '-RACE cDNA, with 5 ' GSP (gene
Special primer, gene-specific primer) or 3 ' GSP and agent box provide UPM (Universal Primer Mix,
Long Primer and Short Primer comprising equal proportion) it is primer.Each reaction is configured to 50 μ L reaction systems, includes 2
25 252 μ L of μ L, 5 ' GSP or 3 ' GSP of μ L, 10 × UPM of μ L, 5 '-RACE cDNA or 3 '-RACE cDNA of × PCR premixed liquid
(10 μM of concentration), ddH2O 16μL.Response procedures: 94 DEG C of initial denaturation 5min；5 circulations (94 DEG C of 30s, 72 DEG C of 3min)；5 are followed
Ring (94 DEG C of 30s, 70 DEG C of 30s, 72 DEG C of 3min)；5 circulations (94 DEG C of 30s, 68 DEG C of 30s, 72 DEG C of 3min)；15 recycle (94 DEG C
30s, 66 DEG C of 30s, 72 DEG C of 3min)；72℃10min；It is down to 25 DEG C.
Nest-type PRC: being respectively amplification template with 5 ' touchdown PCR products and 3 ' touchdown PCR products, with 5 ' NGSP (nested
Gene special primer, nest-type PRC gene-specific primer) or 3 ' NGSP and Short Primer be primer.Each
Reaction is configured to 50 μ L reaction systems, includes 2 × PCR premixed liquid, the 25 μ touchdown PCR of L, 5 ' or 3 ' product, 2 μ L, Short Primer
2 μ L (10 μM of concentration), 2 μ L of 5 ' NGSP or 3 ' NGSP (10 μM of concentration), ddH2O 19μL.Response procedures: 94 DEG C of initial denaturations
5min；35 circulations (94 DEG C of 30s, 65 DEG C of 30s, 72 DEG C of 3min)；72℃10min；It is down to 25 DEG C.
PCR product is sent to Sangon Biotech (Shanghai) Co., Ltd. after the reaction was completed and is sequenced.1.2 result
With analysis
By RACE technology, obtaining the initial transcript of Nlu-mir-9a (primary Nlu-mir-9a), full length sequence is such as
Under: 5 '-ACAUGGGCAUAGUCCGAAAUAUUACAGUAACAUUAUUAAUAAUUAUUACUUUAUUU GUAAUUGUAUCUAC
UAAUAAAUAAAUAUUACAUCAAUUACAUCAAUAUCAGUAGCUCCAUUAAUAUCUGCGAUAGUAGACUUUGAUAUCA
UCAUGGCGAUGGCUGAAGAAAACGACUGAAUCCUUCAAUCUUCAAGAAGGUGCUGACGCUUUCUUUGGUUAUCUAG
CUGUAUGAACGUUCGAUAUCAUAAAGCUAGGUUACCGAAGUUAUUAUCAGCAUCUGAUCUCUGCUCUACACUCACA
CUGCGACUCCCUUCUUUCAAUCAGGCCCCACCAGAGGAUUUUUAUUAUUUAAUUACCAAUUUUGUAAUUAUAACGU
GGACCUCACUAUAGUAGACCAGUUCUCAAUAUUUAUAUUGUAUCUUGCUUUAUUCAGCAUCAUUAUUCAAUAGCAU
AAUUAUUCAAAAAAAAAAAAAAAAAAAAAAAAAA-3’。
The initial transcript overall length of Nlu-mir-9a is 484nt, and poly (A) sequence for being 26nt comprising a segment length is minimum
Free energy is -90.20kcal/mol；Precursor Nlu-mir-9a precursor (precursor Nlu-mir-9a) overall length is
68nt, minimum free energy are -22.90kcal/mol (as shown in Figure 1).Nlu-mir-9a maturation body is the piece of a segment length 22nt
Section, it may be assumed that 5 '-UCUUUGGUUAUCUAGCUGUAUGA-3 '.
2, Nlu-mir-9a regulates and controls NlUbx expression
2.1 materials and methods
2.1.1 microinjection
The injection dosage of Nlu-mir-9a mimics (analogies) and inhibitors (inhibitor) be respectively 100ng and
50ng injects the non-target control of isometric isoconcentration as control, these above-mentioned reagents are by sharp rich biological section
The synthesis of skill Co., Ltd.By reagent agent RNase-free ddH2O is diluted to 5ng/nL concentration.When collecting hatching before experiment
Between consistent incubates nymph, microinjection is carried out when nymph grew to for 3 age.With the CO of throughput about 200mL/min before injection2
15s is anaesthetized to for examination insect, is injected under stereomicroscope with 2010 microinjection instrument of Nanoliter (WPI, the U.S.),
Medicament is by the position injection between brown paddy plant hopper outside of belly mesopodium (thus site carries out injecting caused mechanical damage minimum).It will note
Brown paddy plant hopper after penetrating temporarily is transferred in clean culture dish and is observed, and is transferred on rice seedling and is seen after its recovery
It examines and counts.The expression quantity of sample detection Nlu-mir-9a and NlUbx change when 1d and 3d after injection.3 repetitions of each processing,
10 nymphs of each repetition.
2.1.2 RNA is extracted
Total RNA extract: test sample is placed in the glass homogenizer of Liquid nitrogen precooler be fully ground after, be added 1000 μ L
TransZol Up reagent cracks tissue and cell, and ground extracting solution is transferred to RNase-free centrifuge tube, is stored at room temperature
5min.200 μ L chloroforms are added into centrifuge tube, stand 5min after acutely shaking 30s.In refrigerated centrifuge, in 4 DEG C
12000rpm is centrifuged 15min, and solution is divided into the organic phase of water phase (comprising RNA) and lower layer on upper layer at this time.Upper strata aqueous phase is turned
New centrifuge tube is moved to, the dehydrated alcohol of 1.5 times of volumes is added, stands 30min in -20 DEG C of refrigerators.In 4 DEG C after taking-up
12000rpm is centrifuged 30min, retains and precipitates and abandon most supernatant, and 1000 μ L, 75% ethyl alcohol (RNase-free H is added2O matches
System), acutely shake 30s.It is centrifuged 10min in 4 DEG C of 7500rpm, retains and precipitates and abandon most supernatant, in dry in superclean bench
5-10min.30 μ L RNase-free H are added2O dissolves total RNA.
MiRNA is extracted: referring to miRNeasy Mini Kit (article No. 217004, QIAGEN, the Germany) reagent provided and step
It is rapid to carry out.Test sample is placed in the glass homogenizer of Liquid nitrogen precooler first be fully ground after, be added 700 μ L QIAzol reagents
Crack tissue and cell.The silicon for the being integrated to adsorption column miRNA released specific under the conditions of certain salting liquid and pH
On glue film medium, the small molecular weight impurities such as DNA, protein, salinity are removed by washing step.30 μ L RNase-free are added
H2O elutes miRNA.
2.1.3 cDNA is synthesized
Complementary (cDNA) synthetic reaction of Total RNA is referring to PrimeScript RT reagent Kit
The reagent and step that with gDNA Eraser (article No. RR047, Takara, Japan) is provided carry out.It is with 1 μ g total RNA
Starting template, after removing genomic DNA under the action of gDNA Eraser first, with 6 mers and Oligo dT of Random
Primer is anchor primer, synthesizes cDNA under the action of reverse transcriptase.After reaction in 85 DEG C of heating 5s inactivation reaction bodies
Enzyme in system.By gained cDNA ddH2It is stand-by that -20 DEG C of refrigerators are stored in after O dilution.It is expanded after 10 times of dilution for regular-PCR；
It is reacted after 200 times of dilution for quantitative PCR.
The cDNA synthetic reaction of miRNA is provided referring to II RT kit of miScript (article No. 218160, QIAGEN, Germany)
Reagent and step carry out.Using 1 μ g miRNA as starting template, 5 × miScript HiSpec Buffer is selected, mature is made
MiRNA synthesizes one section of cDNA comprising known joint under the action of reverse transcriptase.It is lost after reaction in 95 DEG C of heating 5min
Enzyme in reaction system living.By gained cDNA ddH2It is stand-by that O is stored in -20 DEG C of refrigerators after diluting 50 times.
2.1.4 quantitative fluorescent PCR
The quantitative fluorescent PCR reaction of mRNA is referring to SYBR Premix Ex Taq II (article No. RR820, Takara, Japan)
The reagent and step of offer carry out.Each reaction is configured to 20 μ L reaction systems, includes 2 × qPCR premixed liquid 10 μ L, 50 × ROX
0.4 μ L of Reference Dye II, cDNA template 8.8 μ L, qPCR after 200 times of dilution react upstream primer and downstream primer
Each 0.4 μ L (10 μM of concentration).QPCR reaction and analysis are in 7300 fluorescence quantitative PCR instrument of Applied Biosystems ABI
It carries out.Response procedures: 95 DEG C of initial denaturation 2min；35 circulations (94 DEG C of 10s, 60 DEG C of 31s).
The quantitative fluorescent PCR of miRNA reacts referencemiScript SYBR Green PCR Kit(article No. 218073,
QIAGEN, Germany) provide reagent and step carry out.Each reaction is configured to 20 μ L reaction systems, includes 2 × qPCR premixed liquid
10 μ L, cDNA template 6 μ L, qPCR after 50 times of dilution react 2 μ L of upstream primer (2 μM of concentration), 10 × miScript
Universal Primer 2μL.QPCR reaction and analysis are in 7300 fluorescence quantitative PCR instrument of Applied Biosystems ABI
Middle progress.Response procedures: 95 DEG C of initial denaturation 15min；35 circulations (94 DEG C of 10s, 55 DEG C of 30s, 70 DEG C of 31s).
According to the method for Livak and Schmittgen (2001), qPCR reacts using house-keeping gene Nlactin1 as internal reference
Gene is used to calculate the relative expression levels of testing gene, relative expression quantity=2^ (Ctactin–Cttest gene) × 100%, wherein
Ct is the recurring number that instrument is read.
2.2 results and analysis
By the mimics (analogies, for being overexpressed Nlu-mir-9a) and inhibitors that synthesize Nlu-mir-9a
(inhibitor, for reducing the transcript abundance of Nlu-mir-9a) carries out microinjection to brown paddy plant hopper 3 age nymph, in vivo verifies
Regulating and controlling effect of the Nlu-mir-9a to NlUbx.
The function and effect of mimics and inhibitors are evaluated first, qPCR the result shows that: the 1st day after injection
When, long wing strain and brachypterism strain nymph injection 100ng mimics after, the expression of Nlu-mir-9a significantly rises respectively
To 2.165 times of control group and 2.599 times；After injection the 3rd day when, long wing strain and brachypterism strain nymph inject 100ng
After mimics, the expression of Nlu-mir-9a is significantly risen respectively to 3.547 times of control group and 1.950 times (Fig. 2A, B institutes
Show).After injection the 1st day when, long wing strain and brachypterism strain nymph injection 50ng inhibitors after, Nlu-mir-9a's
Expression is remarkably decreased respectively to the 32.47% of control group and 47.20%；After injection the 3rd day when, long wing strain and brachypterism
After strain nymph injects 50ng inhibitors, the expression of Nlu-mir-9a is remarkably decreased respectively to control group
24.64% and 46.04% (shown in Fig. 2 C, D).
After injection the 1st day when, long wing strain and brachypterism strain nymph injection 100ng mimics after, the expression of NlUbx
Level is remarkably decreased respectively to the 74.42% of control group and 85.65%；After injection the 3rd day when, long wing strain and brachypterism strain
After nymph injects 100ng mimics, the expression of NlUbx is remarkably decreased respectively to the 68.50% of control group and 79.60%
(shown in Fig. 3 A, B).After injection the 1st day when, long wing strain and brachypterism strain nymph injection 50ng inhibitors after,
The expression of NlUbx is significantly risen respectively to 1.418 times of control group and 1.276 times；After injection the 3rd day when, long wing product
After system and brachypterism strain nymph inject 50ng inhibitors, the expression of NlUbx is significantly risen respectively to control group
Shown in 1.306 times and 1.344 times of Fig. 3 C, D).Show that Nlu-mir-9a can influence the expression of NlUbx by way of negative regulation
It is horizontal.
3, the influence of Ubx gene pairs brown paddy plant hopper survival rate
3.1 materials and methods
3.1.1 double-stranded RNA (dsRNA) is synthesized
For synthesizing the preparation of the template of dsRNA: when PCR amplification is used to synthesize the template of dsRNA, with packet brown paddy plant hopper cDNA
5 ' the ends for template, upstream and downstream amplimer are connected with T7 promoter sequence (T7 sequence: 5 '-
TAATACGACTCACTATAGGG-3').Each PCR reaction is configured to 400 μ L reaction systems, includes 2 × PCR premixed liquid, 200 μ
L, 16 μ L of plasmid template, each 16 μ L of the upstream primer and downstream primer of target gene (10 μM of concentration), 152 μ L of ddH2O.Reaction
Program: 94 DEG C of initial denaturation 5min；35 circulations (94 DEG C of 30s, 60 DEG C of 30s, 72 DEG C of 1min)；72℃10min；It is down to 25 DEG C.
DNA purifying: being settled to 400 μ L with RNase-free H2O for plasmid PCR product, and isometric phenol chloroform examination is added
30s is acutely shaken in agent, is stored at room temperature 5min；In refrigerated centrifuge, it is centrifuged 15min in 4 DEG C of 12000rpm, at this time solution point
For the organic phase of water phase (the including DNA) and lower layer on upper layer.Supernatant is transferred to new centrifuge tube, the nothing of 2 times of volumes is added
The 3M sodium acetate of water-ethanol and 1/10 volume, stands 10min in -20 DEG C of refrigerators.It is centrifuged after taking-up in 4 DEG C of 12000rpm
30min retains precipitating and abandons supernatant to the greatest extent, is added 1000 μ L, 75% ethyl alcohol (RNase-free H2O preparation), acutely shakes 30s.
It is centrifuged 10min in 4 DEG C of 7500rpm, retains precipitating and abandons supernatant to the greatest extent, in 5~10min dry in superclean bench.30 μ L are added
RNase-free H2O dissolving DNA.
DsRNA synthesis: it is synthesis template with plasmid PCR product after purification, synthesizes dsRNA under the action of transcriptase.
Each dsRNA synthetic reaction is configured to 400 μ L reaction systems: including 5 × Transcription buffer, 80 μ L and T7 RNA
Each 10 μ L (40U/ μ of 8 μ L, RNase Inhibitor of 8 μ L of Polymerase (20U/ μ L), ATP, CTP, GTP, UTP (100mM)
L), 10 μ g of template is synthesized, is settled to 400 μ L with RNase-free H2O.37 DEG C of water-bath 4h.
DsRNA purifying: dsRNA synthetic product is settled to 400 μ L with RNase-free H2O, half volume (200 μ are added
L the chloroform of water-saturated phenol and half volume), acutely shakes 30s, is stored at room temperature 5min.In refrigerated centrifuge, in 4 DEG C
12000rpm is centrifuged 10min, and solution is divided into the organic phase of water phase (comprising dsRNA) and lower layer on upper layer at this time.Supernatant is turned
New centrifuge tube is moved to, isometric chloroform is added, acutely shakes 30s, is stored at room temperature 5min.It is centrifuged in 4 DEG C of 12000rpm
Supernatant is transferred to new centrifuge tube by 10min, and the dehydrated alcohol of 2 times of volumes and the 3M sodium acetate of 1/10 volume is added, in-
10min is stood in 20 DEG C of refrigerators.It is centrifuged 30min in 4 DEG C of 12000rpm after taking-up, retains precipitating and abandons supernatant to the greatest extent, 1000 μ are added
75% ethyl alcohol of L, acutely shakes 30s.It is centrifuged 10min in 4 DEG C of 7500rpm, retains precipitating and abandons supernatant to the greatest extent, in superclean bench
Interior dry 5-10min.30 μ L ddH2O dissolution dsRNA is added.
3.1.2 microinjection
Injection dosage for trying dsNlUbx is 150ng, injects the dsGFP of isometric isoconcentration as control.It will be for reagent
Agent RNase-free ddH2O is diluted to 5ng/nL concentration.The consistent incubates nymph of brooding time is collected before experiment, to nymph
Microinjection is carried out when growing to for 3 age.With the CO of throughput about 200mL/min before injection215s is anaesthetized to for examination insect, in body
Injected under stereomicroscope with 2010 microinjection instrument of Nanoliter (WPI, the U.S.), medicament by brown paddy plant hopper outside of belly mesopodium it
Between position injection (thus it is minimum inject caused mechanical damage for site).Brown paddy plant hopper after injection is temporarily transferred to
It is observed in clean culture dish, is transferred on rice seedling after its recovery and is observed and counted.Every for 24 hours after injection
The survival condition of nymph is counted until turning into adult, 3 repetitions of each processing, 50 nymphs of each repetition.
3.2 results and analysis
Injection 150ng dsNlUbx results in the high death rate, and the long wing strain of brown paddy plant hopper and brachypterism strain only have respectively
5.33% and 19.33% nymph can successfully sprout wings, substantially less than control group (73.33% and 88.59%) (as shown in Figure 4).
Almost all of lethal cases all originate from low age and are obstructed to husking when advanced age (or emergence), show as back and occur one obviously
Ecdysial line, but successfully can not slough off old skin, final stiff and feeding and it is dead.
4, Dual-Luciferase Gene Reporter System verifying Nlu-mir-9a is to the negative regulation effect of NlUbx and binding site
4.1 materials and methods
Dual-Luciferase report carrier pmiR-RB-REPORT Vector main composition element is as follows, which can express
Ampicillin resistant gene, fluorescent reporter gene are renilla luciferase gene (hRluc), and fluorescence correction gene is firefly
Luciferase gene (hluc), exogenous sequences insertion point include the restriction enzyme sites such as Not I, Pme I, Xho I, Sgf I (as schemed
Shown in 5).
4.1.1 wild-type reporter vector construction
3 ' UTR sequence of NlUbx amplification: referring to the sequence of 3 ' UTR of NlUbx, the double digestion of design construction wild type carrier
React primer, it may be assumed that WT-Ubx-F 5 '-GCGGCTCGAGGTGGACAGCTAGGTGCTC-3 '；WT-Ubx-R 5'-
AATGCGGCCGCGCTGGTATCTGTTTTTCT-3'.Wherein, CTCGAG is Xho I restriction enzyme site sequence；GCGGCCGC is Not
I restriction enzyme site sequence, the sequence in 5 ' direction of restriction enzyme site are protection base.
Each touchdown PCR reaction is configured to 30 μ L reaction systems, pre- comprising 2 × Phusion High-Fidelity PCR
Mixed liquid (article No. F531S,Thermo Fisher Scientific, the U.S.) 15 3 ' UTR plasmid template of μ L, NlUbx 1 μ L (about
100ng), upstream primer and each 1 μ L of downstream primer (10 μM), ddH2O 12μL.Response procedures: 98 DEG C of initial denaturation 3min.10
Circulation [98 DEG C of 10s, 65 DEG C of 30s (1 DEG C is reduced after each circulation), 72 DEG C of 1min]；25 circulation (98 DEG C of 10s, 60 DEG C of 30s, 72
℃1min)；72℃10min；It is down to 25 DEG C.
Endonuclease reaction: referring to Xho I restriction endonuclease (article No. 1094S, Takara, Japan) and Not I inscribe enzyme reagent kit (goods
Number 1166S, Takara, Japan) reagent that provides and method, double enzyme digestion reaction is carried out to above-mentioned PCR product.Prepare 40 μ L reaction
System includes 10 × H buffer, 4 μ L, 2 μ g, Xho I restriction endonuclease (10U/ μ L) of purified product and Not I restriction endonuclease (10U/ μ L)
Each 1 μ L, uses ddH2O is settled to 40 μ L.In 37 DEG C of reaction 4h.
Connection reaction: digestion products and report carrier are subjected to plasmid recombination.10 μ L reaction systems are prepared, comprising after purification
Digestion products 150ng, pmiR-RB-REPORT Vector 50ng, solution I quickly connect 5 μ L of liquid, use ddH2O is fixed
Hold to 10 μ L.In 16 DEG C of reaction 30min.Obtain wild-type reporter carrier.
4.1.2 1 report carrier of saltant type constructs
Referring to the sequence of 3 ' UTR of NlUbx and the binding site of prediction, the double enzyme digestion reaction of 1 carrier of design construction saltant type
Primer, for being mutated the 1st potential binding site.It, can since the 1st mutational site is close to the initiation site of Insert Fragment
Directly Mut1-Ubx-F and WT-Ubx-R to be utilized to match, PCR reaction, PCR product are carried out by template of 3 ' UTR plasmid of NlUbx
Without splicing, as required 1 report carrier of saltant type.Mut1-Ubx-F 5'-GCGGCTCGAGGTGGACAGCTAGGTGCT
CCACCAGGCGCACGGCGAGGTGGACGGTTTCACTCATAGCAGACATGCC-3'.Wherein, CTCGAG is Xho I digestion position
Point sequence, the sequence in 5 ' direction of restriction enzyme site are protection base.
Each touchdown PCR reaction is configured to 30 μ L reaction systems, pre- comprising 2 × Phusion High-Fidelity PCR
Mixed 15 3 ' UTR plasmid template of μ L, NlUbx of liquid, 1 μ L (about 100ng), upstream primer and each 1 μ L of downstream primer (10 μM), ddH2O
12μL.Response procedures: 98 DEG C of initial denaturation 3min.10 circulations [98 DEG C of 10s, 65 DEG C of 30s (reduce by 1 DEG C) after each circulation, and 72 DEG C
1min]；25 circulations (98 DEG C of 10s, 60 DEG C of 30s, 72 DEG C of 1min)；72℃10min；It is down to 25 DEG C.
Endonuclease reaction: referring to Xho I restriction endonuclease (article No. 1094S, Takara, Japan) and Not I inscribe enzyme reagent kit (goods
Number 1166S, Takara, Japan) reagent that provides and method, double enzyme digestion reaction is carried out to above-mentioned PCR product.Prepare 40 μ L reaction
System includes 10 × H buffer, 4 μ L, 2 μ g, Xho I restriction endonuclease (10U/ μ L) of purified product and Not I restriction endonuclease (10U/ μ L)
Each 1 μ L, uses ddH2O is settled to 40 μ L.In 37 DEG C of reaction 4h.
Connection reaction: digestion products and report carrier are subjected to plasmid recombination.10 μ L reaction systems are prepared, comprising after purification
Digestion products 150ng, pmiR-RB-REPORT Vector 50ng, solution I quickly connect 5 μ L of liquid, use ddH2O is fixed
Hold to 10 μ L.In 16 DEG C of reaction 30min.Obtain 1 report carrier of saltant type.
4.1.3 2 report carrier of saltant type constructs
Referring to the sequence of 3 ' UTR of NlUbx and the binding site of prediction, the double enzyme digestion reaction of 2 carrier of design construction saltant type
Primer, for being mutated the 2nd potential binding site.Mut2-Ubx-F 5'-AGTCAACAGGTTTCTCAACGACTGTCAAAG
GT-3'；Mut2-Ubx-R 5'-GTCGTTGAGAAACCTGTTGACTGCGCCAACTG-3'.The sequence amplification of 2 carrier of saltant type
Need to carry out segmented-PCR reaction: upstream primer (WT-Ubx-F) and downstream mutant primer (Mut2-Ubx-R) are matched；Upstream mutation is drawn
Object (Mut2-Ubx-F) and downstream primer (WT-Ubx-R) are matched.Each touchdown PCR reaction is configured to 30 μ L reaction systems, includes
2 × Phusion High-Fidelity PCR premixed liquid, 15 3 ' UTR plasmid template of μ L, NlUbx, 1 μ L (about 100ng), upstream is drawn
Object and each 1 μ L of downstream primer (10 μM), ddH2O 12μL.Response procedures: 98 DEG C of initial denaturation 3min.10 circulation [98 DEG C of 10s,
65 DEG C of 30s (1 DEG C is reduced after each circulation), 72 DEG C of 1min]；25 circulations (98 DEG C of 10s, 60 DEG C of 30s, 72 DEG C of 1min)；72℃
10min；It is down to 25 DEG C.
The splicing of segmented-PCR product: being configured to 10 μ L reaction systems, pre- comprising 2 × Phusion High-Fidelity PCR
Mixed 5 μ L of liquid, segmented-PCR product each 1 μ L, ddH2O 3μL.Response procedures: 98 DEG C of initial denaturation 3min；8 circulation [98 DEG C of 10s, 60
DEG C 30s (reduces by 1 DEG C) after each circulation, 72 DEG C of 30s]；10 circulations (98 DEG C of 10s, 55 DEG C of 30s, 72 DEG C of 30s)；72℃5min；
It is down to 25 DEG C.
Splicing product PCR reaction: being configured to 30 μ L reaction systems, pre- comprising 2 × Phusion High-Fidelity PCR
Mixed 15 μ L of liquid, above-mentioned splicing product is that template 1 μ L, Mut2-Ubx-F and Mut2-Ubx-R are each 1 μ L (10 μ of upstream and downstream primer
M), ddH2O 12μL.Response procedures: 98 DEG C of initial denaturation 3min；35 circulations (98 DEG C of 10s, 60 DEG C of 30s, 72 DEG C of 1min)；72℃
10min；It is down to 25 DEG C.
Endonuclease reaction: referring to Xho I restriction endonuclease (article No. 1094S, Takara, Japan) and Not I inscribe enzyme reagent kit (goods
Number 1166S, Takara, Japan) reagent that provides and method, double enzyme digestion reaction is carried out to above-mentioned PCR product.Prepare 40 μ L reaction
System includes 10 × H buffer, 4 μ L, 2 μ g, Xho I restriction endonuclease (10U/ μ L) of purified product and Not I restriction endonuclease (10U/ μ L)
Each 1 μ L, uses ddH2O is settled to 40 μ L.In 37 DEG C of reaction 4h.
Connection reaction: digestion products and report carrier are subjected to plasmid recombination.10 μ L reaction systems are prepared, comprising after purification
Digestion products 150ng, pmiR-RB-REPORT Vector 50ng, solution I quickly connect 5 μ L of liquid, use ddH2O is fixed
Hold to 10 μ L.In 16 DEG C of reaction 30min.Obtain 2 report carrier of saltant type.
4.1.4 recombinant plasmid and the measurement of mimics cotransfection and fluorescent value
37 DEG C and 5%CO are lain in for examination 293T cell2Under the conditions of cultivated.The 293T cell of logarithmic growth phase will be in
With every hole 1.5 × 104Cell (100 μ L) is transferred to 96 porocyte culture plates, continues culture in 37 DEG C for 24 hours.Take 10 μ L OPTI-
MEM culture medium (article No. 31985070, GIBCO, the U.S.) dilutes Nlu-mir-9a mimics or non-target control,
15 μ L OPTI-MEM culture mediums dilute the Dual-Luciferase gene report carrier built, the dilution of 25 μ L OPTI-MEM culture mediums
0.25 μ L Lipofectamine, 2000 reagent (article No. 11668027, Invitrogen, the U.S.), by three after the completion of dilution
After flicking mixing, it is stored at room temperature 20min；50 μ L culture mediums are sucked out in each cell culture well, and above-mentioned mixed liquor is added；It is added after 6h
100 μ L fresh cultures.Wherein, mimics transfection concentrations are the hole 50nM/, and report carrier transfection concentrations are the hole 250ng/.Each
Processing is repeated comprising 3 groups of biology, and each repetition sets 3 technologies and repeats.
The examination recommended referring to Dual-Glo Luciferase Assay System (article No. E2920, Promega, the U.S.)
Agent and method carry out fluorescence intensity detection.Before detection, by the luciferase substrate and luciferase buffer in kit
It is saved after being uniformly mixed and dispensing in -80 DEG C, uses forward horizontal stand to room temperature；It will be protected after stop&Glo buffer packing in -80 DEG C
It deposits, using forward horizontal stand to room temperature and takes appropriate addition stop&Glo substrate, it is ready-to-use.Culture medium, every hole is sucked out after transfection 48h
35 μ L PBS buffer solution and 35 μ L luciferase substrates, continuous oscillation 10min is added；Add 30 μ L stop
Reagent, after persistent oscillation 10min.After the reaction was completed, fluorescence intensity is measured using Veritas 9100-002 fluorescence illumination photometer.
4.2 results and analysis
Complete 3 ' UTR sequence of NlUbx is connected to by renilla luciferase gene coding region by double enzyme digestion reaction first
Downstream, construct wild type Dual-Luciferase fusion expression vector.By Nlu-miR-9a mimics (processing group) and non-
Target control (control group) is trained with for examination expression vector cotransfection into human embryonic kidney cell line (HEK293T) respectively
It supports.With firefly luciferase gene (hluc) for fluorescence correction gene, the expression of renilla luciferase gene (hRluc) is detected
Level variation.The result shows that the fluorescence intensity of cell line expression has dropped about compared to control group when transfecting mimics
40.54% (as shown in Figure 6A) shows that Nlu-miR-9a can be encoded suppressor upstream and in conjunction with 3 ' UTR of NlUbx
The expression in area.
In order to further determine the binding site of Nlu-miR-9a and NlUbx, respectively to software prediction go out two it is potential
The carry out rite-directed mutagenesis (CCAAAG sports GGTTTC) of binding site constructs mutant expression vector.It is mutated first combination
When carrying out cotransfection behind site, fluorescence intensity expressed by cell line has still been remarkably decreased 16.72% (as shown in Figure 6B)；It is prominent
Cotransfection is carried out after becoming second binding site, does not have significance difference between fluorescence intensity caused by processing group and control group at this time
It is different (as shown in Figure 6 C), show that second binding site is the true action site of Nlu-miR-9a and NlUbx.
1 mir-9a-5p of table and the forecast analysis of NlUbx action site
5, influence of the Nlu-mir-9a to brown paddy plant hopper survival rate
5.1 materials and methods
5.1.1 microinjection
The injection dosage of Nlu-mir-9a mimics (analogies) is respectively 100ng and 50ng, injects isometric isoconcentration
Non-target control as control, these above-mentioned reagents synthesize by Rui Bo Biotechnology Co., Ltd.It will be for examination
Medicament RNase-free ddH2O is diluted to 5ng/nL concentration.
The consistent incubates nymph of brooding time is collected before experiment, and microinjection is carried out when nymph grew to for 3 age.Before injection
With the CO of throughput about 200mL/min215s is anaesthetized to for examination insect, it is micro- with Nanoliter 2010 under stereomicroscope
Injection instrument (WPI, the U.S.) is injected, and medicament by the position injection between brown paddy plant hopper outside of belly mesopodium, (thus injected by site
Caused mechanical damage is minimum).Brown paddy plant hopper after injection is temporarily transferred in clean culture dish and is observed, it is multiple to it
It is transferred to after Soviet Union on rice seedling and is observed and counted.Survival condition after injection every statistics nymph for 24 hours is until turn into
Adult, 3 repetitions of each processing, 50 nymphs of each repetition.
5.2 results and analysis
Injection 100ng Nlu-mir-9a mimics results in the high death rate, long wing strain and brachypterism strain difference
Only 13.33% and 14.67% nymph can successfully sprout wings, and substantially less than control group (69.33% and 71.33%) is (such as Fig. 7 institute
Show).Almost all of lethal cases all originate from low age and are obstructed to husking when advanced age (or emergence), show as back and occur one
Apparent ecdysial line, but successfully can not slough off old skin, final stiff and feeding and it is dead.When injection relatively low-dose (50ng)
Half or so when mimics, when the death rate is about high dose (100ng) injection.
The embodiments of the present invention have been described in detail above, but content is only the preferred embodiment of the present invention,
It is not intended to limit the invention.All any modifications, equivalent replacements, and improvements etc. done in application range of the invention, should all
It is included within protection scope of the present invention.
SEQUENCE LISTING
<110>Jiangxi Academy of Agricultural Sciences's agricultural microbe research institute (Kitchen Stoves In Rural Areas In Jiangxi Province energy research center)；Central China agriculture
Sparetime university is learned
<120>a kind of miRNA and its application for killing brown paddy plant hopper
<160> 7
<210> 1
<211> 484
<212> RNA
<213>brown paddy plant hopper (Nilaparvata lugens)
<400> 1
acaugggcauaguccgaaauauuacaguaacauuauuaauaauuauuacuuuauuuguaauuguaucuacua
auaaauaaauauuacaucaauuacaucaauaucaguagcuccauuaauaucugcgauaguagacuuugauaucauc
auggcgauggcugaagaaaacgacugaauccuucaaucuucaagaaggugcugacgcuuucuuugguuaucuagcu
guaugaacguucgauaucauaaagcuagguuaccgaaguuauuaucagcaucugaucucugcucuacacucacacu
gcgacucccuucuuucaaucaggccccaccagaggauuuuuauuauuuaauuaccaauuuuguaauuauaacgugg
accucacuauaguagaccaguucucaauauuuauauuguaucuugcuuuauucagcaucauuauucaauagcauaa
uuauucaaaaaaaaaaaaaaaaaaaaaaaaaa
<210> 2
<211> 20
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 2
taatacgactcactataggg
<210> 3
<211> 28
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 3
gcggctcgaggtggacagctaggtgctc
<210> 4
<211> 29
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 4
aatgcggccgcgctggtatctgtttttct
<210> 5
<211> 76
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 5
gcggctcgaggtggacagctaggtgctccaccaggcgcacggcgaggtggacggtttcactcatagcagaca
tgcc
<210> 6
<211> 32
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 6
agtcaacaggtttctcaacgactgtcaaaggt
<210> 7
<211> 32
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 7
gtcgttgagaaacctgttgactgcgccaactg
Claims (10)
1. a kind of miRNA, it is characterised in that the nucleotide sequence of the miRNA is as shown in SEQ ID NO:1.
2. the application that miRNA described in a kind of claim 1 is used to kill brown paddy plant hopper.
3. application according to claim 2, it is characterised in that the application is that the miRNA is injected in brown paddy plant hopper body.
4. application according to claim 3, it is characterised in that the injection dosage of every brown paddy plant hopper is 50~100ng.
5. application according to claim 4, it is characterised in that the brown paddy plant hopper is brown paddy plant hopper nymph.
6. application according to claim 5, it is characterised in that the injection, comprising the following steps: use the miRNA
RNase-free ddH2O is diluted to 5ng/nL concentration；3 age in days brown paddy plant hopper nymphs are taken, are first 180~220mL/min with throughput
CO215s is anaesthetized to the brown paddy plant hopper nymph, then uses microinjection instrument from the brown paddy plant hopper nymph abdomen under stereomicroscope
The miRNA solution after the dilution is injected at position between the mesopodium of face, and miRNA injection dosage is 50~100ng.
7. the application that miRNA described in a kind of claim 1 is used to prepare brown paddy plant hopper protective agents.
8. application according to claim 7, it is characterised in that the dosage form of the drug is injection.
9. application according to claim 7, it is characterised in that the drug effect is born in 3 ' UTR of NlUbx gene
Regulate and control the expression of NlUbx gene.
10. application according to claim 7, it is characterised in that when the drug hinders brown paddy plant hopper to grow to advanced age by low age
Or husking when sprouting wings, the brown paddy plant hopper die of stiff and feeding.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910564291.XA CN110295169B (en) | 2019-06-27 | 2019-06-27 | MiRNA and application thereof in killing Nilaparvata lugens |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910564291.XA CN110295169B (en) | 2019-06-27 | 2019-06-27 | MiRNA and application thereof in killing Nilaparvata lugens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110295169A true CN110295169A (en) | 2019-10-01 |
| CN110295169B CN110295169B (en) | 2022-11-08 |
Family
ID=68029057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910564291.XA Active CN110295169B (en) | 2019-06-27 | 2019-06-27 | MiRNA and application thereof in killing Nilaparvata lugens |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110295169B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111264475A (en) * | 2020-03-09 | 2020-06-12 | 沈阳农业大学 | Microinjection method for small insect adults of whiteflies |
| CN113564167A (en) * | 2021-07-30 | 2021-10-29 | 中山大学 | Rice insect-resistant microRNA and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101203611A (en) * | 2005-04-19 | 2008-06-18 | 巴斯福植物科学有限公司 | Improved methods controlling gene expression |
| CN104293797A (en) * | 2014-10-15 | 2015-01-21 | 中国计量学院 | NlAKTIP gene related to growth and development of brown planthopper as well as encoding protein and application thereof |
-
2019
- 2019-06-27 CN CN201910564291.XA patent/CN110295169B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101203611A (en) * | 2005-04-19 | 2008-06-18 | 巴斯福植物科学有限公司 | Improved methods controlling gene expression |
| US20160152994A1 (en) * | 2005-04-19 | 2016-06-02 | Basf Plant Science Gmbh | Methods controlling gene expression |
| CN104293797A (en) * | 2014-10-15 | 2015-01-21 | 中国计量学院 | NlAKTIP gene related to growth and development of brown planthopper as well as encoding protein and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张宏: "帕金森病患者脑脊液中miR-9a的表达及其临床意义", 《中国医药指南》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111264475A (en) * | 2020-03-09 | 2020-06-12 | 沈阳农业大学 | Microinjection method for small insect adults of whiteflies |
| CN113564167A (en) * | 2021-07-30 | 2021-10-29 | 中山大学 | Rice insect-resistant microRNA and application thereof |
| CN113564167B (en) * | 2021-07-30 | 2023-07-07 | 中山大学 | Rice insect-resistant microRNA and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110295169B (en) | 2022-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106754948B (en) | Nilaparvata lugens NlMLP gene, encoding protein and application thereof | |
| CN114957426B (en) | SP6RARS and application thereof in preventing and treating cockroaches | |
| CN108610427A (en) | Migratory locusts diapause hormone gene and its application in regulating and controlling Insect Diapause | |
| CN111387105A (en) | Method for producing seeds of all-male macrobrachium rosenbergii | |
| CN114921467A (en) | dsRNA (double-stranded ribonucleic acid) based on myzus persicae effect factor MpC002 gene and application thereof in prevention and treatment of myzus persicae | |
| CN110295169A (en) | A kind of miRNA and its application for killing brown paddy plant hopper | |
| CN114853861B (en) | Periplaneta americana PRP protein expression inhibitor, and encoding gene and application thereof | |
| CN103215266B (en) | RNAi and the application thereof of growing for regulating and controlling silkworm pupa | |
| KR102008064B1 (en) | Composition and method of controlling virus mediated by small brown planthopper using dsRNA targeting nuclear receptor E75 gene of small brown planthopper | |
| CN111606989B (en) | Application of reproductive development related gene UCP and dsRNA thereof in prevention and control of bactrocera dorsalis | |
| CN111440823B (en) | Recombinant vector and construction method and application thereof | |
| CN106676112B (en) | Citrus fruit fly Taiman gene and its qRT-PCR detection method and its siRNA | |
| EP2201116A1 (en) | Means and methods for shrna mediated conditional knockdown of genes | |
| CN112574989A (en) | shRNA for inhibiting reproduction of largemouth black bass rhabdovirus and application thereof | |
| CN108949769B (en) | Cotton bollworm ecdysone regulatory factor E78-C gene cDNA and application thereof | |
| CN112522278B (en) | dsRNA (double-stranded ribonucleic acid) designed based on periplaneta americana olfactory receptor gene OR3X, encoding gene, preparation method and application thereof | |
| CN110106179B (en) | dsRNA of locusta migratoria fatty acid synthetase gene LmFAS3 as well as preparation method and application thereof | |
| CN117965544B (en) | MiR-8529-5p for controlling lepidoptera pests and application thereof | |
| CN117965545B (en) | MiR-8492-3p for preventing lepidoptera pests and application thereof | |
| CN116491520B (en) | Application of Tetranychus urticae effector Tu28 gene in regulation and control of Tetranychus urticae | |
| CN112725345B (en) | dsRNA designed based on periplaneta americana sex pheromone receptor gene OR5M, coding gene, preparation method and application thereof | |
| CN118879702A (en) | Application of wheat aphid growth and development related gene RBPs as target in aphid prevention and control | |
| CN118667813A (en) | Botrytis cinerea related grape miR395 gene and target gene APS1 and application thereof | |
| CN115927357A (en) | Apolygus punctatus secretory protein RPSP4043 and application thereof in prevention and control of soybean' symptom green | |
| CN118956870A (en) | Application of wheat aphid growth and development related gene PLRP1 as target in aphid control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |